<DOC>
	<DOCNO>NCT00621517</DOCNO>
	<brief_summary>The purpose study determine bupropion improve symptom restless legs syndrome ( RLS ) .</brief_summary>
	<brief_title>Bupropion Restless Legs Syndrome</brief_title>
	<detailed_description>Adult patient moderate severe RLS recruit study . Those medication treat RLS ask discontinue medication two week prior begin study . All participant screen Beck Depression Inventory , International Restless Legs Syndrome Study Group ( IRLSSG ) severity scale , Clinical Global Impression Improvement ( CGI-I ) scale . An ordinal scale ( i.e . rate symptom 1-8 ) also obtain . Participants randomize placebo medication group . Those medication group give 150 mg bupropion night six week . Others receive similar-appearing placebo . Participants call end week one , two , four five ass symptom severity base IRLSSG scale , determine experience adverse effect . At three week six week , participant return clinic complete four initial form , Beck Depression Inventory , IRLSSG severity scale , ordinal scale , CGI-I .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>clinical diagnosis Restless Legs Syndrome Severity Scale score 15 high History seizure History alcohol use great 2 drink per day occasional binge 5 drink per day Suicidal thoughts/ideations Inability return follow appointment 3 6 week Lack access telephone Eating disorder Age le 18 Pregnancy Unwillingness inability discontinue RLS medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>Bupropion</keyword>
</DOC>